Solventum Corporation SOLV partnered with SprintRay to introduce a groundbreaking solution for digital dentistry, enabling high-quality, same-day dental restorations. This innovative partnership aims to transform dental care by leveraging advanced 3D printing technology, allowing dentists to produce durable restorations with precision and efficiency.
With this collaboration, Solventum reinforces its commitment to advancing dental solutions through cutting-edge innovation. By reducing turnaround time and improving the quality of dental restorations, the partnership empowers dental professionals with seamless, reliable and cost-effective treatment options.
Solventum has joined forces with SprintRay to revolutionize digital dentistry by introducing the first permanent, chairside 3D-printed crown. This partnership combines Solventum’s expertise in advanced dental materials such as Filtek Easy Match Universal Restorative and RelyX Universal Cement with SprintRay’s cutting-edge 3D printing technology. By integrating best-in-class material science with innovative chairside printing solutions, the collaboration aims to transform restorative dentistry, making high-quality, durable crowns and other restorations accessible within a single dental visit.
Through this initiative, Solventum and SprintRay seek to enhance both patient experience and clinical efficiency by reducing chair time, minimizing office visits and lowering treatment costs. With in-office production of crowns, inlays and onlays, dentists and orthodontists can now provide same-day restorations without compromising durability or aesthetics.
By leveraging data science and leading-edge materials, this partnership is poised to set a new industry standard, ensuring that dental professionals can offer faster, more precise and cost-effective restorative solutions.
Per a research report, the global digital dentistry market size was valued at $6 billion in 2024 and is projected to surpass. The figure is expected to be around $19.66 billion by 2034, expanding at a CAGR of 12.6% from 2024 to 2034.
The growth of this market is largely driven by the strong return on investment from digital dentistry equipment and software, the efficiency of same-day dental procedures that minimize patient fatigue and save practitioners valuable time, along with enhancing the cost-effectiveness of modern solutions. Additionally, the rising trend of outsourcing among major dental companies, the increasing demand for aesthetic treatments and a global rise in dental visits are further fuelling market expansion.
Apart from Solventum, several other leading players in the dental industry are making notable advancements in their respective business operations. Here is a look at some of them:
Align Technology, Inc. ALGN continues to enhance its product offerings and research initiatives in orthodontics and dentistry. Recently, Align introduced restorative capabilities for its next-generation iTero Lumina intraoral scanner and the new iTero Lumina Pro dental imaging system. While the iTero Lumina Pro includes Near Infra-Red Imaging technology, the standard iTero Lumina does not. These enhancements streamline restorative and ortho-restorative workflows.
In February, Align announced that the Invisalign Palatal Expander System received approval from the Turkish Medicines and Medical Device Agency and is now available in Turkey. The approval covers a wide range of patients, including growing children, teens and adults.
Another player, Dentsply Sirona XRAY, continues to drive innovation through significant product developments and R&D advancements, reinforcing its leadership in digital dentistry. Per the fourth quarter 2024 earnings transcript, XRAY expanded its Primescan 2, an upgraded intraoral scanner designed to improve accuracy and efficiency in digital impressions, making this more accessible to dental professionals. Additionally, the DS Core platform saw further enhancements, streamlining digital workflows and cloud-based collaboration for seamless integration across dental practices.
In orthodontics, SureSmile Clear Aligners continued to gain traction, benefiting from advancements in treatment planning and material technology. XRAY also introduced new imaging solutions, improving diagnostic precision and clinical outcomes.
Another close peer, Envista Corporation NVST, recently made significant strides in advancing digital dentistry and orthodontic solutions. Recently, DEXIS (currently operates as part of the Envista Equipment and Consumables segment) introduced several new offerings, including a new CBCT platform, enhanced software for the DEXIS intraoral scanner and additional surgical functionality in the DTX treatment planning platform.
Earlier this year, DEXIS launched the DEXIS Ti2 Sensor, the latest innovation to its digital ecosystem with an all-new dental intraoral sensor. It developed DEXIS Connect Pro, a new proactive service platform for DEXIS CBCT and intraoral sensor devices. Altogether, management remains confident about DEXIS being a long-term growth driver for Envista.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Align Technology, Inc. (ALGN) : Free Stock Analysis Report
DENTSPLY SIRONA Inc. (XRAY) : Free Stock Analysis Report
Envista Holdings Corporation (NVST) : Free Stock Analysis Report
Solventum Corporation (SOLV) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.